Guangdong Marubi Biotechnology Co (SHG:603983) — Market Cap & Net Worth
Market Cap & Net Worth: Guangdong Marubi Biotechnology Co (603983)
Guangdong Marubi Biotechnology Co (SHG:603983) has a market capitalization of $1.48 Billion (CN¥10.09 Billion) as of May 2, 2026. Listed on the SHG stock exchange, this China-based company holds position #7454 globally and #1792 in its home market, demonstrating a 3.03% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Guangdong Marubi Biotechnology Co's stock price CN¥25.17 by its total outstanding shares 401000000 (401.00 Million). Analyse 603983 cash generation efficiency to see how efficiently the company converts income to cash.
Guangdong Marubi Biotechnology Co Market Cap History: 2019 to 2026
Guangdong Marubi Biotechnology Co's market capitalization history from 2019 to 2026. Data shows change from $3.43 Billion to $1.48 Billion (-1.95% CAGR).
Guangdong Marubi Biotechnology Co Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Guangdong Marubi Biotechnology Co's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.64x
Guangdong Marubi Biotechnology Co's market cap is 0.64 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.54x
Guangdong Marubi Biotechnology Co's market cap is 5.54 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $3.43 Billion | $1.80 Billion | $514.89 Million | 1.90x | 6.65x |
| 2020 | $2.99 Billion | $1.74 Billion | $464.40 Million | 1.71x | 6.44x |
| 2021 | $1.84 Billion | $1.79 Billion | $247.92 Million | 1.03x | 7.42x |
| 2022 | $1.96 Billion | $1.73 Billion | $174.18 Million | 1.13x | 11.27x |
| 2023 | $1.48 Billion | $2.23 Billion | $259.42 Million | 0.67x | 5.72x |
| 2024 | $1.89 Billion | $2.97 Billion | $341.63 Million | 0.64x | 5.54x |
Competitor Companies of 603983 by Market Capitalization
Companies near Guangdong Marubi Biotechnology Co in the global market cap rankings as of May 2, 2026.
Key companies related to Guangdong Marubi Biotechnology Co by market ranking:
- Procter & Gamble Company (NYSE:PG): Ranked #41 globally with a market cap of $344.11 Billion USD.
- LOREAL ADR 1/5/EO 02 (F:LORA): Ranked #95 globally with a market cap of $204.17 Billion USD ( €174.64 Billion EUR).
- L’Oreal SA (PA:OR): Ranked #104 globally with a market cap of $198.75 Billion USD ( €170.01 Billion EUR).
- Colgate-Palmolive Company (NYSE:CL): Ranked #382 globally with a market cap of $70.34 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #41 | Procter & Gamble Company | NYSE:PG | $344.11 Billion | $147.26 |
| #95 | LOREAL ADR 1/5/EO 02 | F:LORA | $204.17 Billion | €72.00 |
| #104 | L’Oreal SA | PA:OR | $198.75 Billion | €366.05 |
| #382 | Colgate-Palmolive Company | NYSE:CL | $70.34 Billion | $87.26 |
Guangdong Marubi Biotechnology Co Historical Marketcap From 2019 to 2026
Between 2019 and today, Guangdong Marubi Biotechnology Co's market cap moved from $3.43 Billion to $ 1.48 Billion, with a yearly change of -1.95%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.48 Billion | -24.07% |
| 2025 | CN¥1.95 Billion | +2.76% |
| 2024 | CN¥1.89 Billion | +27.66% |
| 2023 | CN¥1.48 Billion | -24.45% |
| 2022 | CN¥1.96 Billion | +6.67% |
| 2021 | CN¥1.84 Billion | -38.51% |
| 2020 | CN¥2.99 Billion | -12.63% |
| 2019 | CN¥3.43 Billion | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Guangdong Marubi Biotechnology Co was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.48 Billion USD |
| MoneyControl | $1.48 Billion USD |
| MarketWatch | $1.48 Billion USD |
| marketcap.company | $1.48 Billion USD |
| Reuters | $1.48 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Guangdong Marubi Biotechnology Co
Guangdong Marubi Biotechnology Co., Ltd. engages in the research and development, design, production, sale, and service of various cosmetics in China. The company provides skin care, make up, and eye care products. It offers its products under the Marubi, Lianhuo, Haruji, and the Love Fire brand names. The company was founded in 2002 and is based in Guangzhou, China.